Doctor Yugo Yamashita

Doctor Yugo Yamashita

Kyoto University Graduate School of Medicine, Kyoto (Japan)

Member of:

Education and Degrees April 2004 – March 2010 ・M.D., Kyoto University Faculty of Medicine April 2015 – March 2019 ・PhD, Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University Previous Professional Experiences April 2019 – March 2021 ・Department of Cardiovascular Medicine, Kyoto University Hospital April 2012 – March 2015 ・Senior Resident (Cardiology), National Hospital Organization Kyoto Medical Center April 2010 – March 2012 ・Junior Resident, National Hospital Organization Kyoto Medical Center Current Positions April 2021 – ・Assistant Professor, Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University; Kyoto University Hospital

Presentations Articles

ONCO DVT Study; Optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer study

Event: ESC Congress 2023

Topic: Cardio-Oncology

Session: HOT LINE 9

Access

The incidence and risk factors of newly-diagnosed cancer after diagnosis of venous thromboembolism: from the COMMAND VTE Registry-2

Event: ESC Congress 2023

Topic: Venous Thromboembolism

Session: Mechanisms of acute pulmonary embolism: lifting the curtain

Access

Autoimmune disorders and venous thromboembolism: A report from the COMMAND VTE Registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Venous Thromboembolism

Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters

Access

Risk factors of recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism: from the COMMAND VTE Registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Venous Thromboembolism

Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters

Access

Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus weekdays: from the COMMAND VTE Registry

Event: ESC Congress 2020

Topic: Venous Thromboembolism

Session: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure ePosters

Access

The association of recurrence and bleeding events with mortality after venous thromboembolism: from the COMMAND VTE Registry

Event: ESC Congress 2019

Topic: Venous Thromboembolism

Session: Acute and anticoagulation

Access

Deep vein thrombosis in upper extremities: clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry

Event: ESC Congress 2019

Topic: Venous Disease

Session: Updates in venous thromboembolism

Access

Duration of anticoagulation in deep vein thrombosis: Guidelines vs. clinical practice.

Event: ESC Congress 2019

Topic: Venous Disease

Session: Hot topics in deep vein thrombosis

Access

Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Progress in anticoagulation for venous thromboembolism

Access

Clinical characteristics and outcomes of atrial fibrillation patients taking direct oral anticoagulants in the real-world: The Fushimi AF Registry

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Yugo Yamashita

Biography

Contributor content

ONCO DVT Study; Optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer study

The incidence and risk factors of newly-diagnosed cancer after diagnosis of venous thromboembolism: from the COMMAND VTE Registry-2

Autoimmune disorders and venous thromboembolism: A report from the COMMAND VTE Registry

Risk factors of recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism: from the COMMAND VTE Registry

Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus weekdays: from the COMMAND VTE Registry

The association of recurrence and bleeding events with mortality after venous thromboembolism: from the COMMAND VTE Registry

Deep vein thrombosis in upper extremities: clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry

Duration of anticoagulation in deep vein thrombosis: Guidelines vs. clinical practice.

Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Clinical characteristics and outcomes of atrial fibrillation patients taking direct oral anticoagulants in the real-world: The Fushimi AF Registry

ESC 365 is supported by

Doctor Yugo Yamashita Follow

Biography

Contributor content

ONCO DVT Study; Optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer study

The incidence and risk factors of newly-diagnosed cancer after diagnosis of venous thromboembolism: from the COMMAND VTE Registry-2

Autoimmune disorders and venous thromboembolism: A report from the COMMAND VTE Registry

Risk factors of recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism: from the COMMAND VTE Registry

Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus weekdays: from the COMMAND VTE Registry

The association of recurrence and bleeding events with mortality after venous thromboembolism: from the COMMAND VTE Registry

Deep vein thrombosis in upper extremities: clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry

Duration of anticoagulation in deep vein thrombosis: Guidelines vs. clinical practice.

Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Clinical characteristics and outcomes of atrial fibrillation patients taking direct oral anticoagulants in the real-world: The Fushimi AF Registry

ESC 365 is supported by

Doctor Yugo Yamashita